TCL Archive FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds February 19, 2010
TCL Archive NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending July 12, 2013
TCL Archive Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer September 23, 1994
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
